首页> 外文期刊>Neuro-Oncology >Diagnostic, treatment and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area
【24h】

Diagnostic, treatment and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area

机译:在旧金山湾区成年脑胶质瘤患者的一项基于人群的研究中,影响生存的诊断,治疗和人口统计学因素

获取原文
获取原文并翻译 | 示例
           

摘要

We compare survival estimates for population-based glioma cases by using two diagnostic coding schemes, (1) the International Classification of Diseases, Oncology, second edition (ICD-O-2) as reported by the Surveillance, Epidemiology, and End Results (SEER) program and (2) central neuropathology review diagnosis based on the World Health Organization II classification. In addition, among review categories, we estimate survival in relation to several patient demographic and treatment factors. Eligible cases included adults residing in the San Francisco Bay SEER Area with newly diagnosed, histo-logically confirmed glioma during the years 1991-1994 and 1997-1999. The study group included participating subjects for whom subsequent central neuropathology review confirmed glioma. We determined treatments, vital status, and other factors by using registry, interview, medical record, and active follow-up data. Survival differences between anaplastic astrocytoma (AA) and astrocytoma were apparent from review diagnoses (median months of survival for AA, 13.0 [95% CI, 9.9-19.5], and astrocytoma, 101.3 [95% CI lower limit, 42.1; upper limit not yet reached]), but not with ICD-O-2 diagnoses reported by SEER (median months of survival for AA, 16.6 [95% CI, 12.0-20.7], and astrocytoma, not otherwise specified, 17.2 [95% CI, 10.6-71.6]). This finding emphasizes the need for improvements in coding for nonglioblastoma astrocytomas to provide better population survival estimates. When review diagnosis was used, younger age and resection (vs. biopsy) were statistically significant for all histology groups analyzed by multi-variable Cox proportional hazard models. Additional statistically significant variables were as follows: among 517 glioblastoma patients, radiation treatment and being married; among 105 AA patients, inclusion of chemotherapy in the initial treatment; and among 106 patients with nonanaplastic oligodendroglial tumors, college education. Further consideration of impact of marital status, education, and other social factors in glioma survival may be warranted.
机译:我们通过使用两种诊断编码方案比较了基于人群的神经胶质瘤病例的生存估计,(1)监测,流行病学和最终结果(SEER)报告的国际疾病分类,肿瘤学,第二版(ICD-O-2) )程序和(2)基于世界卫生组织II分类的中枢神经病理学检查诊断。此外,在评价类别中,我们估计与几种患者人口统计学和治疗因素有关的生存率。符合资格的病例包括在1991年至1994年和1997年至1999年期间居住在旧金山湾SEER地区的成年人,他们经新诊断,组织学证实是神经胶质瘤。该研究小组包括参与受试者,其随后的中枢神经病理学检查证实为神经胶质瘤。我们通过使用注册表,访谈,病历和积极的随访数据来确定治疗方法,生命状态和其他因素。从复查诊断中可以明显看出间变性星形细胞瘤(AA)和星形细胞瘤的生存差异(AA的中位生存时间为13.0 [95%CI,9.9-19.5],星形细胞瘤的生存中位数为101.3 [95%CI下限为42.1;上限没有)。尚未达到]),但未根据SEER报告的ICD-O-2诊断(AA的中位生存时间为16.6 [95%CI,12.0-20.7],星形细胞瘤(未另作说明)为17.2 [95%CI,10.6] -71.6])。这一发现强调需要改进非胶质母细胞瘤星形细胞瘤的编码,以提供更好的种群存活率估计。当使用回顾性诊断时,对于通过多变量Cox比例风险模型分析的所有组织学组,年龄和切除(相对于活检)均具有统计学意义。其他统计学上显着的变量如下:517例胶质母细胞瘤患者中,接受放射治疗和已婚;在105名AA患者中,在初始治疗中包括化疗;在106例非变性少突胶质细胞瘤患者中,接受过大学教育。可能需要进一步考虑婚姻状况,教育程度和其他社会因素对神经胶质瘤生存的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号